🔗 Share this article

An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on messaging platforms, according to recent findings.

Investigational Treatment Acquiring Traction Online

Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are encouraged to message these profiles privately for source information, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a flourishing market exists on Telegram, where groups with thousands of members share comparison images, injection guides and claims of rapid British shipping. Sellers promote the drug there before redirecting customers to WhatsApp for purchases.

Understanding The Experimental Drug

This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials indicate it could assist patients reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and chemists have warned that the sale of what remains an unlicensed drug in the United Kingdom is a cause for concern and could result in individuals administering substances of unknown origin.

Some experts stated the popularity for the experimental drug could be linked to the increasing cost of approved weight loss products such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.

Some influencers try to circumvent the regulations by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate medicines, advertising, and customer regulations, potentially leading to penalties, legal action or imprisonment.

Platform Response and Content Removal

According to the social media company, the platform has taken down violative content and banned associated hashtags and search suggestions. The company stated it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Online Trading Activities

Investigations also discovered groups with up to nine thousand participants marketing the experimental drug using the platform's built-in discovery tool, which functions like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at residence.

Within moments of entering one community, a vendor posted contact information, where the majority of transactions occur. The vendor provided an guidebook and guaranteed shipping within two days. When questioned whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about weight, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, messages show dark colored parcels with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, prepared at home with sterile water, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give contradictory responses varying between a several days to “depends on your body”.

Service Oversight and Security Actions

A representative for the messaging service said it regularly moderated harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is valid, these digital products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

A medical professional of Asda Online Doctor connected the surge in demand to current price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are turning to social media. But fake treatments are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she explained.

Her team has previously encountered patients injured by personal administration from unconfirmed sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a company investigational substance not yet approved … may subject patients to possibly significant medical dangers”.